The implantable neurostimulation device activates the body's innate anti-inflammatory and immune-restorative pathways ...

The FDA just approved the SetPoint System, which electrically stimulates the vagus nerve to control inflammation from the ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

The SetPoint System is an implanted device that stimulates the vagus nerve once a day. It was tested through a clinical trial at Northwell Health.

The FDA has approved the SetPoint System, a neuroimmune modulation device, for the treatment of adults with moderately to ...